Cargando…
Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection
A 32-year-old woman with a history of symptomatic supraventricular tachycardia, inappropriate sinus tachycardia, and hyperadrenergic POTS was treated with ivabradine and metoprolol. She then presented with bradycardia and Mobitz II second-degree AV block on event monitoring six weeks after COVID-19...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405341/ https://www.ncbi.nlm.nih.gov/pubmed/34471549 http://dx.doi.org/10.1155/2021/7809231 |
_version_ | 1783746313120120832 |
---|---|
author | Ocher, Rebecca A. Padilla, Erika Hsu, Jonathan C. Taub, Pam R. |
author_facet | Ocher, Rebecca A. Padilla, Erika Hsu, Jonathan C. Taub, Pam R. |
author_sort | Ocher, Rebecca A. |
collection | PubMed |
description | A 32-year-old woman with a history of symptomatic supraventricular tachycardia, inappropriate sinus tachycardia, and hyperadrenergic POTS was treated with ivabradine and metoprolol. She then presented with bradycardia and Mobitz II second-degree AV block on event monitoring six weeks after COVID-19 infection. Her post-viral workup revealed normalization of catecholamine levels and significant symptomatic improvement in heart rate. To the authors' knowledge, this is the first reported case of improvement in POTS after COVID-19 infection. As our understanding of COVID-19 continues to improve, it will be vital to better understand the impact of COVID-19 dysautonomia on cardiac patients. |
format | Online Article Text |
id | pubmed-8405341 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-84053412021-08-31 Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection Ocher, Rebecca A. Padilla, Erika Hsu, Jonathan C. Taub, Pam R. Case Rep Cardiol Case Report A 32-year-old woman with a history of symptomatic supraventricular tachycardia, inappropriate sinus tachycardia, and hyperadrenergic POTS was treated with ivabradine and metoprolol. She then presented with bradycardia and Mobitz II second-degree AV block on event monitoring six weeks after COVID-19 infection. Her post-viral workup revealed normalization of catecholamine levels and significant symptomatic improvement in heart rate. To the authors' knowledge, this is the first reported case of improvement in POTS after COVID-19 infection. As our understanding of COVID-19 continues to improve, it will be vital to better understand the impact of COVID-19 dysautonomia on cardiac patients. Hindawi 2021-08-18 /pmc/articles/PMC8405341/ /pubmed/34471549 http://dx.doi.org/10.1155/2021/7809231 Text en Copyright © 2021 Rebecca A. Ocher et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Ocher, Rebecca A. Padilla, Erika Hsu, Jonathan C. Taub, Pam R. Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection |
title | Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection |
title_full | Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection |
title_fullStr | Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection |
title_full_unstemmed | Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection |
title_short | Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection |
title_sort | clinical and laboratory improvement in hyperadrenergic postural orthostatic tachycardia syndrome (pots) after covid-19 infection |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405341/ https://www.ncbi.nlm.nih.gov/pubmed/34471549 http://dx.doi.org/10.1155/2021/7809231 |
work_keys_str_mv | AT ocherrebeccaa clinicalandlaboratoryimprovementinhyperadrenergicposturalorthostatictachycardiasyndromepotsaftercovid19infection AT padillaerika clinicalandlaboratoryimprovementinhyperadrenergicposturalorthostatictachycardiasyndromepotsaftercovid19infection AT hsujonathanc clinicalandlaboratoryimprovementinhyperadrenergicposturalorthostatictachycardiasyndromepotsaftercovid19infection AT taubpamr clinicalandlaboratoryimprovementinhyperadrenergicposturalorthostatictachycardiasyndromepotsaftercovid19infection |